Researchers have developed a method to extract living cells from feces that they say could help conservationists better ...

Hydrogen trucks debut in Georgia, sparking debates on costs and green freight gains. Kurt “CyberGuy" Knutsson comments on ...

Their work is expected to have applications in the surveillance of environmental chemicals and, ultimately, the diagnosis of critical diseases including neurological and cardiovascular diseases and ...

Their work is expected to have applications in the surveillance of environmental chemicals and, ultimately, the diagnosis of critical diseases including neurological and cardiovascular diseases and ...

You are a biologist researching blood cancers – when did you develop an interest in science? I grew up in Hungary, and when I was about 12 I read a book by the Hungarian Nobel Prize-winner ...

Using in-vitro models of a specific type of brain cell, scientists have demonstrated that neurons can transform from one type to another. Neurons are specialized brain cells responsible for ...

In a breakthrough with promising real-world applications, a team of Rutgers biophysicists, bioengineers, and plant biologists has captured the first live images. In a groundbreaking study, researchers ...

Researchers have developed a cutting-edge chip technology capable of precisely mimicking the interactions between cancer cells and blood vessels, akin to the human body environment. This innovation is ...

Findings could open up new avenue for precision therapy for the most commonly diagnosed cancer among women that killed 670,000 in 2022 alone A team of Chinese scientists has uncovered a key mechanism ...

David A. Drew, PhD, of the Clinical & Translational Epidemiology Unit and Division of Gastroenterology at Massachusetts General Hospital, is the corresponding author of a paper published in Cellular ...

Apr. 15, 2025 — Researchers have demonstrated a way to use corn protein to improve the performance of lithium-sulfur batteries, a finding that holds promise for expanding the use of the high ...

Apr. 11, 2025 — A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for specifically targeting AML cells in patients who relapsed following other treatments.